PA006 Assignment Global Healthcare Issues

Global Healthcare Issue

HIV/AIDS

Description

An infection with the HIV virus reduces the ability to ward off infections by attacking CD4 cells (T cells) causes AIDS (Nhlongolwane & Shonisani, 2023). HIV/AIDS continues to be a major public health problem world-wide. An estimated 39.9 million people were living with HIV at the end of 2023, with 1.3 million new HIV infections reported that year and 630,000 deaths due to HIV-related disease reported. Although treatment and TB prevention has improved over the years there is still disparities, particularly in LMICs.

Country

United States

South Africa

Describe the policy in each country related to the identified healthcare issue.

The United States addresses HIV/AIDS primarily through the President’s Emergency Plan for AIDS Relief (PEPFAR), established in 2003. PEPFAR focuses on prevention, treatment, and support services, both domestically and internationally, with significant funding allocated to global HIV/AIDS initiatives.

South Africa implements its National Strategic Plan (NSP) on HIV, TB, and STIs, aiming to reduce new HIV infections and provide comprehensive care. The NSP emphasizes universal access to treatment, prevention programs, and addressing social determinants contributing to the epidemic.

Explain the strengths and weaknesses of each policy.

Strengths: PEPFAR has significantly reduced HIV transmission rates and expanded access to antiretroviral therapy globally.

Weaknesses: Critics argue that PEPFAR’s funding allocations can be influenced by political agendas, potentially limiting comprehensive sexual education programs.

Strengths: South Africa’s NSP is comprehensive, targeting both prevention and treatment while addressing social factors (Ordóñez et al., 2023).

Weaknesses: Implementation challenges persist due to resource constraints and healthcare infrastructure limitations.

Explain how the social determinants of health may impact the global healthcare issue you selected. Be specific and provide examples.

In the U.S., socioeconomic status, education, and healthcare access significantly impact HIV prevalence. Marginalized communities, such as low-income populations and racial minorities, face higher infection rates due to limited access to prevention and treatment. For example, southern states like Mississippi and Alabama, with high poverty rates, report some of the highest HIV infections due to healthcare provider shortages and inadequate public funding. Education also plays a role—many young Black and Hispanic men who have sex with men (MSM) lack comprehensive sexual health education, increasing their risk. Healthcare access remains a barrier, especially in states that did not expand Medicaid under the ACA, where HIV treatment gaps persist. Stigma and discrimination further discourage testing and treatment, particularly among undocumented immigrants and transgender individuals. Expanding Medicaid, mobile testing, and culturally competent healthcare can help reduce these disparities and improve outcomes.

In South Africa, poverty, gender inequality, and limited healthcare access exacerbate HIV transmission. High levels of unemployment and poor living conditions often lead to overcrowding, increasing the risk of HIV spread. Gender-based violence (GBV) is a significant factor, as women in abusive relationships may struggle to negotiate safe sex practices, making them more vulnerable to infection. According to the South African National AIDS Council (SANAC), women aged 15-24 are disproportionately affected, with HIV prevalence rates significantly higher than their male counterparts. Economic disparities also force many women into transactional sex, further increasing their risk of exposure. Additionally, in rural areas where healthcare facilities are scarce, delayed HIV testing and treatment initiation contribute to continued transmission. For example, in KwaZulu-Natal, one of the provinces with the highest HIV prevalence, community outreach programs have been implemented to improve access to testing and antiretroviral therapy (ART), but logistical challenges persist.

Analyze how each country’s government addressed cost, quality, and access related to the global healthcare issue selected.

The U.S. government, through PEPFAR, allocates substantial funding to ensure high-quality HIV care and broad access to antiretroviral therapy, both domestically and internationally (Nhlongolwane & Shonisani, 2023). However, domestic healthcare costs can be prohibitive for uninsured individuals.

The South African government provides free antiretroviral treatment in public healthcare facilities, striving for universal access. Nonetheless, disparities in healthcare quality and access persist, particularly in rural areas.

Explain how the healthcare policy you selected might impact the global population. Be specific and provide examples.

The President’s Emergency Plan for AIDS Relief (PEPFAR) has been instrumental in reducing global HIV/AIDS mortality rates and preventing new infections, showcasing the U.S.’s commitment to global health. Since its inception in 2003, PEPFAR has invested over $110 billion in HIV/AIDS response, making it the largest global health initiative focused on a single disease. This initiative has supported more than 20 million people worldwide with access to ART, contributing to a 47% decline in global HIV-related deaths since 2010. One of its most impactful programs, the DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe) initiative, has successfully reduced HIV incidence among adolescent girls and young women in sub-Saharan Africa. In Kenya, for instance, DREAMS has contributed to a 25% decline in new HIV infections among young women between 2015 and 2022 by providing education, economic empowerment, and access to HIV prevention methods such as pre-exposure prophylaxis (PrEP). Additionally, in Zambia, PEPFAR-funded initiatives have strengthened the healthcare system by integrating electronic medical records and scaling up viral load monitoring, ensuring better patient management and treatment adherence.

South Africa’s National Strategic Plan (NSP) for HIV, TB, and STIs serves as a model for other high-burden countries, demonstrating the effectiveness of a comprehensive national strategy in combating HIV/AIDS (Rejane Caetani et al., 2025). The NSP prioritizes a multi-sectoral approach that integrates prevention, treatment, and community engagement, ensuring that all population groups—especially vulnerable communities—receive adequate support. One key success has been the rollout of the Test and Treat initiative, which ensures that individuals diagnosed with HIV are immediately linked to antiretroviral therapy (ART) to prevent disease progression and reduce transmission rates. Countries like Eswatini and Kenya have adopted similar approaches, inspired by South Africa’s NSP framework. For example, Eswatini, with one of the world’s highest HIV prevalence rates, successfully reduced new infections by over 40% between 2010 and 2020 by implementing strategies aligned with South Africa’s NSP, such as early ART initiation and widespread community testing campaigns. The effectiveness of the NSP highlights how evidence-based policies can significantly impact national and regional HIV control efforts.

Explain how the healthcare policy you selected might impact the role of the nurse in each country.

In the U.S., nurses play a critical role in implementing PEPFAR initiatives by providing education, testing, and treatment services, both domestically and abroad. Within the U.S., nurses in community health centers and hospitals work to expand HIV testing and counseling, particularly in high-risk populations, such as men who have sex with men (MSM) and Black and Latino communities, which are disproportionately affected by HIV. For example, in Washington, D.C., a city with one of the highest HIV prevalence rates in the country, nurses actively lead mobile testing units to reach at-risk individuals and connect them with PrEP or ART services. Internationally, U.S.-trained nurses deployed under PEPFAR work in HIV/AIDS clinics in partner countries, providing mentorship and capacity-building for local healthcare workers. In Uganda, PEPFAR-supported nurse-led programs have enhanced early infant HIV diagnosis by integrating point-of-care testing in maternal health clinics, increasing early ART initiation rates among newborns. These nurse-led efforts significantly contribute to global HIV/AIDS control by improving healthcare accessibility and ensuring the sustainability of HIV treatment programs in resource-limited settings.

In South Africa, nurses are at the forefront of the NSP’s implementation, often serving as the primary healthcare providers in underserved communities, where doctor-to-patient ratios are critically low. They deliver essential HIV services, including testing, counseling, treatment initiation, and ongoing ART management. Many nurses are also involved in preventive measures such as distributing pre-exposure prophylaxis (PrEP) and promoting condom use. For instance, the Nurse-Initiated Management of Antiretroviral Therapy (NIMART) program has empowered nurses to prescribe ART, significantly expanding treatment access in rural and peri-urban areas. In a township like Khayelitsha, where HIV prevalence is high, nurses run community health clinics that not only provide ART but also offer education on safer sex practices and maternal transmission prevention. Their role is crucial in reducing stigma and encouraging individuals to seek timely medical care.

Explain how global health issues impact local healthcare organizations and policies in both countries. Be specific and provide examples.

Global HIV/AIDS initiatives influence U.S. healthcare organizations by encouraging the adoption of best practices in prevention and treatment while fostering international collaboration. Lessons learned from global programs, such as South Africa’s NSP and PEPFAR-funded initiatives in Africa, have led to improvements in the U.S. HIV response. For example, the concept of differentiated service delivery (DSD), which allows stable HIV patients to receive multi-month ART prescriptions and reduces the burden on healthcare facilities, has been increasingly adopted in U.S. clinics serving marginalized populations. Furthermore, global initiatives emphasize the importance of community-led HIV interventions, inspiring U.S. healthcare organizations to integrate peer support programs and culturally tailored prevention strategies. In cities like San Francisco, the success of community-based HIV prevention programs—modeled after PEPFAR-funded projects in Africa—has led to significant reductions in new infections, contributing to the city’s goal of achieving zero new HIV transmissions. Additionally, the expansion of telemedicine for HIV care, a strategy widely utilized in global settings with limited healthcare infrastructure, has been implemented across rural parts of the U.S. to enhance access to specialist care. By integrating global best practices into local HIV/AIDS responses, U.S. healthcare organizations continue to refine and improve strategies for prevention, diagnosis, and treatment.

Global health partnerships play a pivotal role in strengthening South Africa’s HIV response by providing financial support, technical assistance, and innovative healthcare solutions. Organizations such as the Global Fund to Fight AIDS, Tuberculosis, and Malaria and the President’s Emergency Plan for AIDS Relief (PEPFAR) have invested billions in HIV prevention, treatment, and healthcare infrastructure. For example, PEPFAR funds community-led interventions that focus on adolescent girls and young women, a demographic highly affected by HIV. These initiatives include mentorship programs, educational support, and access to PrEP. Additionally, global partnerships have facilitated the implementation of differentiated service delivery (DSD) models, which allow stable HIV patients to receive multi-month ART prescriptions, reducing the burden on healthcare facilities. In 2023, a collaboration between the Bill & Melinda Gates Foundation and the South African Medical Research Council (SAMRC) led to the development of long-acting injectable PrEP, which has the potential to revolutionize HIV prevention efforts in high-risk populations.

General Notes/Comments

The United States has been a global leader in HIV/AIDS response, primarily through the President’s Emergency Plan for AIDS Relief (PEPFAR), initiated in 2003. PEPFAR has significantly contributed to global efforts in combating HIV/AIDS, especially in sub-Saharan Africa. Domestically, the U.S. has implemented various strategies to reduce HIV transmission and provide care to those affected. However, challenges remain, including addressing disparities in healthcare access among marginalized populations and ensuring sustained funding for prevention and treatment programs.

South Africa bears a significant burden of the HIV/AIDS epidemic, with one of the highest prevalence rates globally. The government has implemented comprehensive strategies, including the National Strategic Plan (NSP) on HIV, TB, and STIs, aiming to reduce new infections and provide treatment to those affected. Despite these efforts, challenges such as healthcare infrastructure limitations, stigma, and socioeconomic disparities continue to hinder progress. The recent freeze in U.S. aid has raised concerns about the continuity of HIV/AIDS programs, but the South African government has committed to sustaining these initiatives.